Advertisement
Advertisement
U.S. Markets open in 8 hrs 54 mins
Advertisement
Advertisement
Advertisement
Advertisement

Manhattan Scientifics, Inc. (MHTX)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.0110-0.0020 (-15.38%)
At close: 09:31AM EDT
Advertisement

Manhattan Scientifics, Inc.

244 Fifth Avenue
Suite 2341
New York, NY 10001
United States
212 541 2405
https://www.mhtx.com

Sector(s)Healthcare
IndustryMedical Devices
Full Time Employees

Key Executives

NameTitlePayExercisedYear Born
Mr. Marvin MaslowFounder & ChairmanN/AN/A1938
Mr. Emmanuel TsoupanariasPres, CEO & Director186kN/A1953
Mr. Leonard C. FriedmanSec.N/AN/A1938
Mr. Robert Romeo ProulxPres of ImagionN/AN/A1958
Amounts are as of December 31, 2021 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Manhattan Scientifics, Inc., a technology incubator, engages in the development and commercialization of life-enhancing technologies in the United States. It develops technologies in the areas of nano-technologies and nano-medicine. The company was formerly known as Grand Enterprises, Inc. Manhattan Scientifics, Inc. was founded in 1992 and is based in New York, New York.

Corporate Governance

Manhattan Scientifics, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Advertisement
Advertisement